Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review

P Csermely, T Korcsmáros, HJM Kiss, G London… - Pharmacology & …, 2013 - Elsevier
Despite considerable progress in genome-and proteome-based high-throughput screening
methods and in rational drug design, the increase in approved drugs in the past decade did …

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

DB Kell - BMC medical genomics, 2009 - Springer
Background The production of peroxide and superoxide is an inevitable consequence of
aerobic metabolism, and while these particular'reactive oxygen species'(ROSs) can exhibit a …

HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology

C Gille, C Bölling, A Hoppe, S Bulik… - Molecular systems …, 2010 - embopress.org
We present HepatoNet1, the first reconstruction of a comprehensive metabolic network of
the human hepatocyte that is shown to accomplish a large canon of known metabolic liver …

Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics

M Brown, WB Dunn, P Dobson, Y Patel, CL Winder… - Analyst, 2009 - pubs.rsc.org
The chemical identification of mass spectrometric signals in metabolomic applications is
important to provide conversion of analytical data to biological knowledge about metabolic …

Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles

J Tang, T Aittokallio - Current pharmaceutical design, 2014 - ingentaconnect.com
Polypharmacology has emerged as novel means in drug discovery for improving treatment
response in clinical use. However, to really capitalize on the polypharmacological effects of …

A review on computational systems biology of pathogen–host interactions

S Durmuş, T Çakır, A Özgür, R Guthke - Frontiers in microbiology, 2015 - frontiersin.org
Pathogens manipulate the cellular mechanisms of host organisms via pathogen–host
interactions (PHIs) in order to take advantage of the capabilities of host cells, leading to …

In silico models of cancer

LB Edelman, JA Eddy, ND Price - … Reviews: Systems Biology …, 2010 - Wiley Online Library
Cancer is a complex disease that involves multiple types of biological interactions across
diverse physical, temporal, and biological scales. This complexity presents substantial …

Systems medicine and metabolic modelling

A Mardinoglu, J Nielsen - Journal of internal medicine, 2012 - Wiley Online Library
Mardinoglu A, Nielsen J (University of Technology, Gothenburg, Sweden). Systems
medicine and metabolic modelling (Key Symposium). J Intern Med 2012; 271: 142–154 …

Integrating cellular metabolism into a multiscale whole-body model

M Krauss, S Schaller, S Borchers… - PLoS computational …, 2012 - journals.plos.org
Cellular metabolism continuously processes an enormous range of external compounds into
endogenous metabolites and is as such a key element in human physiology. The …

PubChem as a source of polypharmacology

B Chen, D Wild, R Guha - Journal of chemical information and …, 2009 - ACS Publications
Polypharmacology provides a new way to address the issue of high attrition rates arising
from lack of efficacy and toxicity. However, the development of polypharmacology is …